Takeda to Expand 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Announces 340B Webinar for Grantees Before Upcoming Recertification Begins

HRSA building and signage
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.
The Health Resources and Services Administration (HRSA) has announced plans to host a webinar for federal grantees just days prior [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Three More States Introduce 340B Contract Pharmacy Protection Bills

Sen. Louise Lucas
Virginia state Sen. Louise Lucas this month introduced a 340B contract pharmacy bill. Influential state senators in Kentucky and Florida also recently introduced similar bills.
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

First 340B Provider Reporting Bill of the Year Introduced in Indiana

Indiana state Sen. Ed Charbonneau has introduced a bill that would require 340B providers to annually report financial information on their 340B programs.
A senior Indiana state senator introduced a bill this week that would require 340B providers to annually report detailed financial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Warns of ‘Adverse Impact’ from Lack of 340B Provisions in New MA Rule

Ashley Thompson headshot
AHA's Ashley Thompson wrote that a proposed Medicare Advantage payment rule could have “double the adverse impact” on 340B hospitals.
The nation’s leading hospital group warned the decision by federal regulators not to address 340B policy in a new proposed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

US Eighth Circuit Court of Appeals building
A decision upholding Arkansas' state contract pharmacy law from the U.S. 8th Circuit Court of Appeals could cause more states to push similar laws, attorneys and lobbyists said.
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

HRSA provider audits
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

US Capitol
Congress is unlikely to pass a 340B program overhaul in 2024 unless there is unexpected pressure from appellate court decisions or a Senate "group of 6" breakthrough, attorneys and lobbyists said.
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live